24.09.2025 – 08:55UmweltBündnis Entwicklung HilftWorldRiskReport 2025: Billions threatened by floodingmehr
11.09.2025 – 11:20FinanzenOryx Stainless AGExtension of credit lines continues stable support for Oryx Stainless' dynamic growth strategymehr
02.05.2025 – 19:27DHL Group2PM: Aktionäre der Deutsche Post AG beschließen Dividende auf Vorjahresniveau; Katrin Suder neue Aufsichtsratsvorsitzende / PR: Deutsche Post AG shareholders approve dividend at previous year's level; Katrin Suder new Chair of the Supervisory Board2 Dokumentemehr
03.05.2024 – 20:06DHL Group2PM: Aktionäre der Deutsche Post AG beschließen Dividende auf Vorjahresniveau; Vorstand kündigt Einziehung von Aktien an / PR: Deutsche Post AG shareholders approve dividend at previous year’s level; Board of Management announces withdrawal of shares2 Dokumentemehr
29.02.2024 – 10:01WiN Emscher-Lippe9Football fans from Europe visit the champion of structural change in GelsenkirchenEin Dokumentmehr
25.05.2023 – 18:50Wissen / BildungBrainRepair UGBirth weight and head circumference predict IQ and motor performance at 4 years of agemehr
08.02.2023 – 13:26Gesundheit / MedizinBrainRepair UGBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully fundedmehr
28.11.2022 – 11:18KW automotive GmbH4KW automotive group presents a broadly based motorsport and accessory program at the Essen Motor Show 2022Ein Dokumentmehr
19.11.2021 – 11:42KW automotive GmbH4KW automotive group at Essen Motor Show 2021: Grand appearance of all KW brands together with BBSEin Dokumentmehr
18.11.2021 – 10:25BBS automotive GmbH2Tradition meets Technology: BBS at the Essen Motor ShowEin Dokumentmehr
27.05.2021 – 10:35WirtschaftBrainRepair UGInvestment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15Mmehr
30.09.2020 – 13:00Wissen / BildungBrainRepair UGRegulatory breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns /EMA Orphan Drug Designation is followed by agreement on Paediatric Investigation Planmehr